Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma

Pediatric Research

Volumn 61, Issue 4, 2007, Pages 496-501

  Roth, Christian L ^a   Hunneman, Donald H ^b   Gebhardt, Ursel ^c   Stoffel Wagner, Birgit ^d   Reinehr, Thomas ^e   Müller, Hermann L ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; CATECHOLAMINE; CREATININE; HOMOVANILLIC ACID; NORADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CATECHOLAMINE RELEASE; CRANIOPHARYNGIOMA; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS DISEASE; HYPOTHALAMUS TUMOR; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; MICTURITION; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN METABOLISM; QUESTIONNAIRE; SYMPATHETIC TONE; URINALYSIS;

ADOLESCENT; ADULT; CRANIOPHARYNGIOMA; DOPAMINE; EPINEPHRINE; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; NOREPINEPHRINE; OBESITY; SYMPATHETIC NERVOUS SYSTEM; VANILMANDELIC ACID;

EID: 34147141924     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/pdr.0b013e3180332cd6     Document Type: Article

References (21)

1. Geffner M, Lundberg M, Koltowska-Haggstrom M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B 2004 Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89:5435-5440
2. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA 2005 Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397-409
3. Kendall-Taylor P, Jonsson PJ, Abs R, Erfurth EM, Koltowska-Haggstrom M, Price DA, Verhelst J 2005 The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 152:557-567
4. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E 2004 Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220-229
5. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
6. Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sörensen N 2004 Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89:3298-3305
7. Harz KJ, Müller HL, Waldeck E, Pudel V, Roth C 2003 Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:5227-5231
8. Schwartz MW, Woods SC, Porte DJr, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
9. Bray GA 2000 Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int J Obes Relat Metab Disord 24:S8-S17
10. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
11. Hunneman DH 1983 Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasma. Clin Chim Acta 135:169-174
12. Müller HL, Bruhnken G, Emser A, Faldum A, Etavard-Gorris N, Gebhardt U, Kolb R, Sörensen N 2005 Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst 21:975-980
13. Wolff JE, Daumling E, Dirksen A, Dabrock A, Hartmann M, Jurgens H 1996 Munster Heidelberg Abilities Scale - a measuring instrument for global comparison of illness sequelae. Klin Padiatr 208:294-298
14. Young JB, Landsberg L 1998 Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams Textbook of Endocrinology, 9th ed. WB Saunders Co, Philadelphia, pp 665-728
15. Eisenhofer G, Kopin IJ, Goldstein DS 2004 Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331-349
16. Grove KL, Smith MS 2003 Ontogeny of the hypothalamic neuropeptide Y system. Physiol Behav 79:47-63
17. Ricquier D, Bouillaud F, Toumelin P, Mory G, Bazin R, Arch J, Penicaud L 1986 Expression of uncoupling protein mRNA in thermogenic or weakly thermogenic brown adipose tissue. Evidence for a rapid beta-adrenoreceptor-mediated and transcriptionally regulated step during activation of thermogenesis. J Biol Chem 261:13905-13910
18. Schofl C, Schleth A, Berger D, Terkamp C, von zur Mühlen A, Brabant G 2002 Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. J Clin Endocrinol Metab 87:624-629
19. Coutant R, Maurey H, Rouleau S, Mathieu E, Mercier P, Limal JM, Le Bouil A 2003 Defect in epinephrine production in children with craniopharyngioma: functional or organic origin? J Clin Endocrinol Metab 88:5969-5975
20. Mason PW, Krawiecki N, Meacham LR 2002 The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156:887-892
21. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT 2004 Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89:81-86